David Zehendner has launched Vida Nova Solutions, a premier animal nutrition company offering a broad selection of antibiotic alternative products and customized formulations. A 26-year veteran of the animal health and feed industry, Zehendner serves as the president and CEO of Vida Nova.
“I started this company with one clear goal: provide customers with superior products that generate a positive return on investment,” Zehendner said. “The global market for Vida Nova’s feed ingredient alternatives and nutritional supplements is enormous, and we are uniquely positioned to meet these needs.”
In the wake of 2017 FDA regulations banning the broad use of antibiotics in livestock feed, producers are turning to quality antibiotic alternatives to boost animal health and productivity. Vida Nova’s line of propriety enzyme blends, Mannan Oligosaccharides (MOS), beta glucans, and pro and prebiotics are already in high demand.
In addition to standalone products, Vida Nova specializes in manufacturing customized formulations. Superior manufacturing practices ensure that each batch exceeds the most stringent quality standards in the world so customers can be confident they are receiving a consistent, pure and efficacious product every time.
According to Markets and Markets research, the animal feed additive market share is expected to exceed $28 billion by 2022. The global feed enzyme market is estimated to reach $1.4 billion by 2022 at a compound annual growth rate of 9.1 percent. Growth in the market is driven by increased global meat consumption, antibiotic bans around the world and greater awareness of meat quality. Enzyme-based feed additives reduce feed costs, promote greater nutrient absorption and as a result, yield the environmental benefits of decreased animal waste.